What is the typical age of onset for tinea capitis in pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Age of Onset for Tinea Capitis

Tinea capitis predominantly affects prepubertal children, with peak incidence occurring between 3 and 7 years of age, while infants in their first year of life are less frequently affected. 1, 2, 3

Typical Age Distribution

  • The peak age range is 3-7 years old, representing the most common period for tinea capitis infection 2, 3
  • Prepubertal children are the primary affected population, with the condition being predominantly a disorder of this age group 1
  • Children over 6 years of age and before puberty represent the typical demographic, with African Americans being the most affected group in North America 2

Age-Related Clinical Patterns

  • Infants are less frequently affected compared to older children, though cases can occur even in the first year of life 1
  • Tinea capitis is rare in children under 2 years old, with documented cases ranging from as young as 10 days old to 2 years, with a median age of 3 months in this younger cohort 4
  • Adult incidence is generally low, but when it occurs, it is more commonly seen in immunocompromised individuals where the presentation may be atypical 1

Important Clinical Considerations

  • The rarity of tinea capitis in infants under 1-2 years means it is often misdiagnosed and underreported because it resembles other scalp pathologies such as seborrheic dermatitis or eczema 5, 4
  • When erythematous scalp lesions with scaling or alopecia are present in infants, mycological examination should be performed to avoid missing this diagnosis 5
  • The predominant causative organism varies by geography, with Trichophyton tonsurans accounting for 50-90% of cases in the UK and being the most common organism in North America, while Microsporum canis remains most common across Europe 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Tinea capitis.

Medical mycology, 2000

Research

Tinea Capitis: An Updated Review.

Recent patents on inflammation & allergy drug discovery, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.